Cipla Shares Drop Amid Competition Concerns Following Keytruda Biosimilar Deal

Indian pharmaceutical company Cipla saw its stock decline after announcing a Keytruda biosimilar partnership with Qilu Pharmaceutical, as investors worry about intensifying market competition.

4 Sept, 05:41 — 4 Sept, 05:41

Post Share

Sources

Showing 1 of 1 sources

moneycontrol8h ago

Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley... - Moneycontrol.com

Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley... Moneycontrol.com

Read full article →

Cipla Shares Drop Amid Competition Concerns Following Keytruda Biosimilar Deal

Sources

Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley... - Moneycontrol.com

Related Stories

Chinese rare earth firms halt some US shipments over geopolitical worries

Volkswagen Unveils Sweeping Restructuring Plan Including Massive Job Cuts

Strong U.S. Jobs Data Fuels Rate Hike Bets as Trump Threatens Trade Tariffs

Norway’s Sovereign Wealth Fund Plans Major Reduction in U.S. Treasury Holdings